Irritable bowel syndrome is the most common functional gastrointestinal disorder,
manifesting as abdominal pain/discomfort and altered bowel function. Despite affecting as …

The understanding of irritable bowel syndrome (IBS) has undergone a rapid evolution with
scientific advancement. IBS is a common functional bowel disorder that generates a …

Based on clinical studies, the Rome Criteria for the irritable bowel syndrome (IBS) were
developed by consensus. The criteria emphasize the presence of abdominal pain and the …

Irritable bowel syndrome (IBS), a chronic gastrointestinal disorder, affects from 3–20% of the
US population, depending on sociocultural and comorbid factors. IBS is characterized by a …

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder, frequently managed
by general practitioners and gastroenterologists. It is a complex condition, characterized by …

Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
disorder that affects 9%-23% of the population across the world. The percentage of patients …

Irritable bowel syndrome (IBS) is a commonly encountered condition seen in multiple
medical specialties. Recent research has brought dramatic advances in our understanding …

There are frequent advances in knowledge about the clinical presentation, pathophysiology,
and treatment of irritable bowel syndrome. It is important for clinicians to be aware of …

Irritable bowel syndrome (IBS) is one of the most common conditions that is encountered in
general medical practices [1, 2]. It has the potential for protean manifestations, but generally …

Importance The prevalence of irritable bowel syndrome (IBS) in the United States is between
7% and 16%, most common in women and young people, with annual direct costs estimated …